Clinical Trial Update: Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531

View source ↗

Summary

Update on a completed study of gemtuzumab ozogamicin therapy in DNA samples from patients with acute myeloid leukemia treated in the COG-AAML0531 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Status: COMPLETED